The regulatory mark of PRMT6-mediated asymmetric dimethylation of histones is a well-known mechanism that can either activate or repress gene expression [52], and our previous study demonstrated that PRMT6 can enhance the transcription of CDC20 in glioblastoma cells via H3R2me2a [19]. The gene discussed is CDC20; the disease is glioblastoma.